Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation.

Xu H, Van der Jeught K, Zhou Z, Zhang L, Yu T, Sun Y, Li Y, Wan C, So KM, Liu D, Frieden M, Fang Y, Mosley AL, He X, Zhang X, Sandusky GE, Liu Y, Meroueh SO, Zhang C, Wijeratne AB, Huang C, Ji G, Lu X

Open source

DOI: 10.1172/jci146832
Published: 2021 May 17
Container: The Journal of clinical investigation
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci146832,
  title = {Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation.},
  author = {Xu H and Van der Jeught K and Zhou Z and Zhang L and Yu T and Sun Y and Li Y and Wan C and So KM and Liu D and Frieden M and Fang Y and Mosley AL and He X and Zhang X and Sandusky GE and Liu Y and Meroueh SO and Zhang C and Wijeratne AB and Huang C and Ji G and Lu X},
  year = {2021},
  journal = {The Journal of clinical investigation},
  doi = {10.1172/jci146832},
  url = {https://doi.org/10.1172/jci146832}
}

RIS

TY  - JOUR
TI  - Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation.
AU  - Xu H
AU  - Van der Jeught K
AU  - Zhou Z
AU  - Zhang L
AU  - Yu T
AU  - Sun Y
AU  - Li Y
AU  - Wan C
AU  - So KM
AU  - Liu D
AU  - Frieden M
AU  - Fang Y
AU  - Mosley AL
AU  - He X
AU  - Zhang X
AU  - Sandusky GE
AU  - Liu Y
AU  - Meroueh SO
AU  - Zhang C
AU  - Wijeratne AB
AU  - Huang C
AU  - Ji G
AU  - Lu X
PY  - 2021
JO  - The Journal of clinical investigation
DO  - 10.1172/jci146832
UR  - https://doi.org/10.1172/jci146832
ER  -

APA

H, X., K, V. D. J., Z, Z., L, Z., T, Y., Y, S., Y, L., C, W., KM, S., D, L., M, F., Y, F., AL, M., X, H., X, Z., GE, S., Y, L., SO, M., C, Z., AB, W., C, H., G, J., & X, L. (2021). Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation.. The Journal of clinical investigation. https://doi.org/10.1172/jci146832

Source records

pubmed · retrieved 2026-09-25T01:02:19.827Z